Carl Atkinson to Lung Transplantation
This is a "connection" page, showing publications Carl Atkinson has written about Lung Transplantation.
Connection Strength
3.430
-
Pro-inflammatory IgG1 N-glycan signature correlates with primary graft dysfunction onset in COPD patients. Transpl Immunol. 2022 04; 71:101491.
Score: 0.707
-
Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant. Front Immunol. 2021; 12:711102.
Score: 0.695
-
A novel injury site-natural antibody targeted complement inhibitor protects against lung transplant injury. Am J Transplant. 2021 06; 21(6):2067-2078.
Score: 0.673
-
Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury. Am J Respir Cell Mol Biol. 2019 06; 60(6):678-686.
Score: 0.597
-
Donor pretreatment with nebulized complement C3a receptor antagonist mitigates brain-death induced immunological injury post-lung transplant. Am J Transplant. 2018 10; 18(10):2417-2428.
Score: 0.551
-
Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways? Ann Thorac Surg. 2006 Oct; 82(4):1212-8.
Score: 0.062
-
Use of 18FDG-pet to discriminate between infection and rejection in lung transplant recipients. Transplantation. 2004 May 15; 77(9):1462-4.
Score: 0.053
-
Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 2004 May; 23(5):527-31.
Score: 0.052
-
MicroRNA-206 antagomiR?enriched extracellular vesicles attenuate lung ischemia?reperfusion injury through CXCL1 regulation in alveolar epithelial cells. J Heart Lung Transplant. 2020 12; 39(12):1476-1490.
Score: 0.041